MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41375-025-02685-5

Медицинская библиотека · Leukemia · 2025

The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia.

Rettinger Eva, Heckl Dirk, Gibson Brenda, Sauer Martin, Turkiewicz Dominik, Kleinschmidt Katharina, Kalwak Krzysztof, Reinhardt Dirk, Locatelli Franco, Klusmann Jan-Henning, Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Allogeneic hematopoietic stem cell transplantation (HSCT) has significantly improved the outcome of children with high-risk (HR) acute myeloid leukemia (AML). Implementing allogeneic HSCT depends on numerous factors, including adverse cytogenetics, molecular abnormalities, poor response to first-line treatment, or relapsed or primary refractory disease. In HR AML, allogeneic HSCT is considered to be the consolidation strategy of choice in first complete remission (CR1) and offers the best chance of cure for patients with relapsed disease. Advances in donor/recipient typing, conditioning regimens, graft-versus-host-disease (GvHD) management, and supportive care have contributed to this improvement in overall-and transplant-outcome. This review will comprehensively discuss indications for HSCT and its modalities in pediatric AML by examining past, current, and future strategies for disease- and response-related stratification. We will examine the key importance of low/negative measurable residual disease (MRD) before transplantation and discuss conditioning regimens and graft variables, as well as novel approaches to harness the graft-versus-leukemia (GvL) effect, including targeted immunotherapy. The review will also address toxicities associated with HSCT, GvHD prophylaxis, and the management of treatment failure. Ultimately, this review seeks to inform clinical practice and highlights how improved outcomes have been achieved through the collective efforts of international study groups.

Для цитирования: Rettinger Eva, Heckl Dirk, Gibson Brenda, Sauer Martin, Turkiewicz Dominik, Kleinschmidt Katharina, Kalwak Krzysztof, Reinhardt Dirk, Locatelli Franco, Klusmann Jan-Henning, Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia.. Leukemia. 2025. DOI: 10.1038/s41375-025-02685-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.